RGNX
REGENXBIO Inc.
+0.22 (+2.76%)8.20USD497K成交股數541M市值–本益比(近四季)3.1股價營收比+405.7%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 2 · 949K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 718K · 1 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 949K · 887K |
| 近 180 天 淨額 | 62K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 09-03 | Chan Mitchell | Chief Financial Officer | F 繳稅扣股 | 4.9K | 9.32 | 46K | 123K | SEC |
| 2026-09-01 | 09-03 | Malzahn Craig | Chief Technology Officer | F 繳稅扣股 | 234 | 9.32 | 2K | 82.0K | SEC |
| 2026-08-27 | 08-27 | Ciongoli Gregory Austin | Director | P 公開市場買進 | 53.4K | 9.36 | 500K | 118K | SEC |
| 2026-08-26 | 08-27 | Ciongoli Gregory Austin | Director | P 公開市場買進 | 49.2K | 9.14 | 450K | 64.6K | SEC |
| 2026-08-25 | 08-27 | Ciongoli Gregory Austin | Director | A 獲配股票 | 15.4K | – | – | 15.4K | SEC |
| 2026-08-01 | 08-04 | PAKOLA STEVE | Chief Medical Officer | F 繳稅扣股 | 7.5K | 9.69 | 72K | 206K | SEC |
| 2026-08-01 | 08-04 | Christmas Patrick J. | Chief Strategy & Legal Officer | F 繳稅扣股 | 4.7K | 9.69 | 46K | 206K | SEC |
| 2026-07-02 | 07-06 | PAKOLA STEVE | Chief Medical Officer | M 選擇權執行 | 2.2K | 7.86 | 17K | 215K | SEC |
| 2026-07-02 | 07-06 | PAKOLA STEVE | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.2K | 13.64 | 29K | 213K | SEC |
| 2026-07-01 | 07-06 | Simpson Curran | Chief Executive Officer | F 繳稅扣股 | 6.8K | 13.09 | 89K | 338K | SEC |
| 2026-07-01 | 07-01 | PAKOLA STEVE | Chief Medical Officer | S 公開市場賣出 | 36.7K | 12.86 | 472K | 213K | SEC |
| 2026-07-01 | 07-01 | PAKOLA STEVE | Chief Medical Officer | M 選擇權執行 | 36.7K | 7.86 | 289K | 250K | SEC |
| 2026-06-30 | 07-06 | Simpson Curran | Chief Executive Officer | A 獲配股票 | 1.5K | 10.18 | 15K | 345K | SEC |
| 2026-06-29 | 07-01 | PAKOLA STEVE | Chief Medical Officer | S 公開市場賣出 | 19.6K | 11.04 | 216K | 213K | SEC |
| 2026-05-29 | 06-02 | Bennett Jean | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | Glucksmann Alexandra | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | Fox Allan M. | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | Mills Kenneth T. | Director | A 獲配股票 | 9.8K | – | – | 496K | SEC |
| 2026-05-29 | 06-02 | STUMP DAVID C | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | Tasse Daniel | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | KARABELAS ARGERIS N | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-29 | 06-02 | Zachary Jennifer | Director | A 獲配股票 | 9.8K | – | – | 31.9K | SEC |
| 2026-05-29 | 06-02 | MIGAUSKY GEORGE V | Director | A 獲配股票 | 9.8K | – | – | 28.9K | SEC |
| 2026-05-11 | 05-13 | PAKOLA STEVE | Chief Medical Officer | S 公開市場賣出(10b5-1) | 15.3K | 11.02 | 169K | 233K | SEC |
| 2026-03-10 | 03-12 | PAKOLA STEVE | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.1K | 10.35 | 53K | 248K | SEC |
| 2026-02-01 | 02-03 | Christmas Patrick J. | Chief Strategy & Legal Officer | F 繳稅扣股 | 4.7K | 11.16 | 52K | 211K | SEC |
| 2026-02-01 | 02-03 | PAKOLA STEVE | Chief Medical Officer | F 繳稅扣股 | 5.3K | 11.16 | 59K | 253K | SEC |
| 2026-01-27 | 01-29 | Mills Kenneth T. | Director | F 繳稅扣股 | 222K | 13.41 | 3.0M | 486K | SEC |
| 2026-01-27 | 01-29 | Mills Kenneth T. | Director | M 選擇權執行 | 225K | 13.09 | 2.9M | 708K | SEC |
| 2026-01-06 | 01-08 | Simpson Curran | Chief Executive Officer | A 獲配股票 | 145K | – | – | 342K | SEC |
| 2026-01-06 | 01-08 | Christmas Patrick J. | Chief Strategy & Legal Officer | A 獲配股票 | 73.7K | – | – | 215K | SEC |
| 2026-01-06 | 01-08 | PAKOLA STEVE | Chief Medical Officer | A 獲配股票 | 65.8K | – | – | 258K | SEC |
| 2026-01-06 | 01-08 | Malzahn Craig | Chief Technology Officer | A 獲配股票 | 65.8K | – | – | 82.2K | SEC |
| 2026-01-06 | 01-08 | Chan Mitchell | Chief Financial Officer | A 獲配股票 | 73.7K | – | – | 128K | SEC |
| 2026-01-02 | 01-06 | Simpson Curran | Chief Executive Officer | F 繳稅扣股 | 18.6K | 14.40 | 267K | 198K | SEC |
| 2026-01-02 | 01-06 | Malzahn Craig | Chief Technology Officer | F 繳稅扣股 | 1.2K | 14.40 | 18K | 16.3K | SEC |
| 2026-01-02 | 01-06 | PAKOLA STEVE | Chief Medical Officer | F 繳稅扣股 | 18.2K | 14.40 | 263K | 192K | SEC |
| 2026-01-02 | 01-06 | Christmas Patrick J. | Chief Strategy & Legal Officer | F 繳稅扣股 | 9.8K | 14.40 | 141K | 142K | SEC |
| 2025-12-31 | 07-06 | Simpson Curran | Chief Executive Officer | A 獲配股票 | 951 | 7.00 | 7K | 343K | SEC |
| 2025-10-09 | 10-10 | Simpson Curran | Chief Executive Officer | S 公開市場賣出(10b5-1) | 20.8K | 12.62 | 263K | 216K | SEC |
| 2025-09-29 | 10-01 | Simpson Curran | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.6K | 10.03 | 76K | 237K | SEC |
| 2025-09-10 | 09-12 | Simpson Curran | Chief Executive Officer | S 公開市場賣出(10b5-1) | 7.7K | 10.02 | 77K | 245K | SEC |
| 2025-09-01 | 09-03 | Malzahn Craig | Chief Technology Officer | F 繳稅扣股 | 234 | 8.93 | 2K | 17.6K | SEC |
| 2025-09-01 | 09-03 | Chan Mitchell | Chief Financial Officer | F 繳稅扣股 | 4.9K | 8.93 | 44K | 54.0K | SEC |
| 2025-08-01 | 08-04 | Christmas Patrick J. | Chief Strategy & Legal Officer | F 繳稅扣股 | 4.7K | 8.19 | 38K | 151K | SEC |
| 2025-07-01 | 07-03 | Simpson Curran | Chief Executive Officer | F 繳稅扣股 | 4.7K | 8.23 | 39K | 252K | SEC |
| 2025-05-30 | 06-03 | KARABELAS ARGERIS N | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | Bennett Jean | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | Zachary Jennifer | Director | A 獲配股票 | 7.8K | – | – | 22.1K | SEC |
| 2025-05-30 | 06-03 | Tasse Daniel | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | STUMP DAVID C | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | Mills Kenneth T. | Director | A 獲配股票 | 7.8K | – | – | 483K | SEC |
| 2025-05-30 | 06-03 | MIGAUSKY GEORGE V | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | Fox Allan M. | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-30 | 06-03 | Glucksmann Alexandra | Director | A 獲配股票 | 7.8K | – | – | 19.1K | SEC |
| 2025-05-12 | 05-14 | Mills Kenneth T. | Director | M 選擇權執行 | 20.6K | 3.76 | 77K | 496K | SEC |
| 2025-05-12 | 05-14 | Mills Kenneth T. | Director | S 公開市場賣出(10b5-1) | 20.6K | 7.91 | 163K | 475K | SEC |
| 2025-03-27 | 03-31 | Mills Kenneth T. | Director | M 選擇權執行 | 30.8K | 3.76 | 116K | 475K | SEC |
| 2025-02-01 | 04-04 | Christmas Patrick J. | Chief Legal Officer | F 繳稅扣股 | 4.7K | 8.07 | 38K | 156K | SEC |
| 2025-02-01 | 04-04 | PAKOLA STEVE | Chief Medical Officer | F 繳稅扣股 | 5.3K | 8.07 | 42K | 211K | SEC |
| 2025-02-01 | 04-04 | Danos Olivier | Chief Scientific Officer | F 繳稅扣股 | 5.5K | 8.07 | 44K | 226K | SEC |
| 2025-01-02 | 01-06 | Simpson Curran | Chief Executive Officer | F 繳稅扣股 | 11.9K | 7.73 | 92K | 158K | SEC |
| 2025-01-02 | 01-06 | Danos Olivier | Chief Scientific Officer | F 繳稅扣股 | 12.6K | 7.73 | 98K | 172K | SEC |
| 2025-01-02 | 01-06 | PAKOLA STEVE | Chief Medical Officer | A 獲配股票 | 64.3K | – | – | 216K | SEC |
| 2025-01-02 | 01-06 | Simpson Curran | Chief Executive Officer | A 獲配股票 | 98.9K | – | – | 257K | SEC |
| 2025-01-02 | 01-06 | PAKOLA STEVE | Chief Medical Officer | F 繳稅扣股 | 13.9K | 7.73 | 107K | 152K | SEC |
| 2025-01-02 | 01-06 | Christmas Patrick J. | Chief Legal Officer | F 繳稅扣股 | 11.4K | 7.73 | 88K | 161K | SEC |
| 2025-01-02 | 01-06 | Danos Olivier | Chief Scientific Officer | A 獲配股票 | 59.3K | – | – | 232K | SEC |
| 2024-10-01 | 10-02 | KARABELAS ARGERIS N | Director | M 選擇權執行 | 10.0K | 3.76 | 38K | 21.3K | SEC |
| 2024-10-01 | 10-02 | KARABELAS ARGERIS N | Director | S 公開市場賣出(10b5-1) | 10.0K | 10.11 | 101K | 11.3K | SEC |
| 2024-09-16 | 09-18 | Chan Mitchell | Chief Financial Officer | A 獲配股票 | 58.9K | – | – | 58.9K | SEC |
| 2024-09-03 | 09-04 | KARABELAS ARGERIS N | Director | M 選擇權執行 | 10.0K | 3.76 | 38K | 21.3K | SEC |
| 2024-09-03 | 09-04 | KARABELAS ARGERIS N | Director | S 公開市場賣出(10b5-1) | 700 | 12.34 | 9K | 11.3K | SEC |
| 2024-09-03 | 09-04 | KARABELAS ARGERIS N | Director | S 公開市場賣出(10b5-1) | 9.3K | 11.50 | 107K | 12.0K | SEC |
| 2024-08-08 | 08-12 | Mills Kenneth T. | Director | M 選擇權執行 | 36.3K | 0.85 | 31K | 444K | SEC |
| 2024-08-01 | 08-05 | KARABELAS ARGERIS N | Director | M 選擇權執行 | 100 | 12.74 | 1K | 21.4K | SEC |
| 2024-08-01 | 08-05 | KARABELAS ARGERIS N | Director | M 選擇權執行 | 10.0K | 3.76 | 38K | 21.3K | SEC |
| 2024-08-01 | 08-05 | Simpson Curran | Chief Executive Officer | S 公開市場賣出(10b5-1) | 100 | 15.00 | 2K | 170K | SEC |
| 2024-08-01 | 08-05 | Danos Olivier | Chief Scientific Officer | A 獲配股票 | 58.9K | – | – | 185K | SEC |
| 2024-08-01 | 08-05 | KARABELAS ARGERIS N | Director | S 公開市場賣出(10b5-1) | 9.6K | 13.45 | 129K | 11.8K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.4M | 76.6M | +615K (+11%) | 加碼 |
| Redmile Group, LLC | 4.4M | 52.3M | 不變 | 持平 |
| STATE STREET CORP | 3.0M | 35.6M | +240K (+9%) | 加碼 |
| JPMORGAN CHASE & CO | 2.2M | 26.2M | −1.3M (-36%) | 減碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | 25.2M | +100K (+5%) | 加碼 |
| MORGAN STANLEY | 2.0M | 23.4M | −113K (-5%) | 減碼 |
| GOLDMAN SACHS GROUP INC | 1.4M | 17.0M | −418K (-23%) | 減碼 |
| AQR CAPITAL MANAGEMENT LLC | 1.4M | 16.5M | +327K (+31%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.4M | 16.2M | +337K (+33%) | 加碼 |
| MARSHALL WACE, LLP | 1.3M | 15.4M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | 14.9M | +104K (+9%) | 加碼 |
| Integral Health Asset Management, LLC | 800K | 9.6M | −700K (-47%) | 減碼 |
| Nuveen, LLC | 740K | 8.9M | +158K (+27%) | 加碼 |
| DIMENSIONAL FUND ADVISORS LP | 732K | 8.8M | −279K (-28%) | 減碼 |
| 德劭 D. E. Shaw & Co., Inc. | 713K | 8.5M | +427K (+149%) | 加碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 670K | 8.0M | +115K (+21%) | 加碼 |
| 城堡 CITADEL ADVISORS LLC | 669K | 8.0M | 新進 | 新進 |
| STIFEL FINANCIAL CORP | 561K | 6.7M | +168K (+43%) | 加碼 |
| BANK OF AMERICA CORP /DE/ | 519K | 6.2M | +194K (+60%) | 加碼 |
| 22NW, LP | 493K | 5.9M | 不變 | 持平 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 481K | 5.8M | +196K (+69%) | 加碼 |
| Pale Fire Capital SE | 466K | 5.6M | −27.5K (-6%) | 減碼 |
| NORTHERN TRUST CORP | 422K | 5.1M | +28.2K (+7%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 396K | 4.7M | +5.8K (+1%) | 加碼 |
| LAZARD ASSET MANAGEMENT LLC | 370K | 4.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 165 -13 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 25 / 38 / 58 / 51 |
| 機構合計持股 · 佔流通股 | 42.4M · 64.2% |
| 合計季末市值 | 504M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.5M |
|---|---|
| 與上期比 | -8.5% |
| 佔流通股數 | 11.36% |
| 日均成交量 | 1.5M |
| 回補天數 | 4.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.5M | -8.5% | 11.36% | 1.5M | 4.9 |
| 2026-08-14 | 8.2M | +13.9% | 12.42% | 1.1M | 7.8 |
| 2026-07-31 | 7.2M | -16.6% | 10.90% | 1.9M | 3.8 |
| 2026-07-15 | 8.6M | -17.5% | 13.07% | 2.6M | 3.3 |
| 2026-06-30 | 10.5M | +12.9% | 15.84% | 3.3M | 3.2 |
| 2026-06-15 | 9.3M | +11.8% | 14.03% | 1.3M | 7.0 |
| 2026-05-29 | 8.3M | +16.1% | 12.55% | 1.8M | 4.5 |
| 2026-05-15 | 7.1M | +6.6% | 10.81% | 2.2M | 3.2 |
| 2026-04-30 | 6.7M | -3.6% | 10.14% | 552K | 12.1 |
| 2026-04-15 | 6.9M | +3.5% | 10.52% | 550K | 12.6 |
| 2026-03-31 | 6.7M | +3.8% | 10.17% | 830K | 8.1 |
| 2026-03-13 | 6.5M | +1.3% | 9.80% | 1.1M | 5.7 |
| 2026-02-27 | 6.4M | +6.5% | 9.67% | 706K | 9.1 |
| 2026-02-13 | 6.0M | +23.0% | 9.09% | 1.1M | 5.6 |
| 2026-01-30 | 4.9M | -4.8% | 7.39% | 1.3M | 3.6 |
| 2026-01-15 | 5.1M | +3.1% | 7.76% | 744K | 6.9 |
| 2025-12-31 | 5.0M | -2.7% | 7.53% | 679K | 7.3 |
| 2025-12-15 | 5.1M | -5.8% | 7.74% | 661K | 7.7 |
| 2025-11-28 | 5.4M | +14.4% | 8.22% | 688K | 7.9 |
| 2025-11-14 | 4.7M | +4.2% | 7.18% | 577K | 8.2 |
| 2025-10-31 | 4.5M | -6.8% | 6.89% | 526K | 8.6 |
| 2025-10-15 | 4.9M | -2.1% | 7.39% | 685K | 7.1 |
| 2025-09-30 | 5.0M | -1.6% | 7.55% | 518K | 9.6 |
| 2025-09-15 | 5.1M | -1.4% | 7.67% | 445K | 11.4 |
| 2025-08-29 | 5.1M | -6.1% | 7.78% | 633K | 8.1 |
| 2025-08-15 | 5.5M | -0.3% | 8.29% | 718K | 7.6 |